期刊
UROLOGIA INTERNATIONALIS
卷 100, 期 3, 页码 271-278出版社
KARGER
DOI: 10.1159/000487645
关键词
Urinary tract infection; Cystitis; Pyelonephritis; Therapy; Systematic review; Clinical guideline
资金
- Leo Pharma
- Astellas
- Monika Kutzner Stiftung
- Pfizer
- Bionorica
- Daiichi Sanchyo
- MerLion
- OM-Pharma
- Rosen Pharma
- Zambon
- Basilea
- Enteris
- Helperby
- Rosen-Pharma
- Akademie der Deutschen Urologen
- CGC Cramer
- Fischerappelt
- Fresenius
- Gilead
- Infectopharm
- MDS
- MedConcept
- MIM-Verlag
- Omega/Abtei
- Pfleger
- Springer-Verlag
- Strathmann Thieme-Verlag
- Uromed
- Achaogen
- AstraZeneca
- Cubist
- Galenus
- MSD
- Pierre Fabre
- Pierelle Research
- Calixa
- DFG
- Europ
Background: We aimed to update the 2010 evidence- and consensus-based national clinical guideline on the diagnosis and management of uncomplicated urinary tract infections (UTIs) in adult patients. Results are published in 2 parts. Part 1 covers methods, the definition of patient groups, and diagnostics. This second publication focuses on treatment of acute episodes of cystitis and pyelonephritis as well as on prophylaxis of recurrent UTIs. Materials and Methods: An interdisciplinary group consisting of 17 representatives of 12 medical societies and a patient representative was formed. Systematic literature searches were conducted in MEDLINE, EMBASE, and the Cochrane Library to identify literature published in 2010-2015. Results: For the treatment of acute uncomplicated cystitis (AUC), fosfomycin-trometamol, nitrofurantoin, nitroxoline, pivmecillinam, and trimethoprim (depending on the local rate of resistance) are all equally recommended. Cotrimoxazole, fluoroquinolones, and cephalosporins are not recommended as antibiotics of first choice, for concern of an unfavorable impact on the microbiome. Mild to moderate uncomplicated pyelonephritis should be treated with oral cefpodoxime, ceftibuten, ciprofloxacin, or levofloxacin. For AUC with mild to moderate symptoms, instead of antibiotics symptomatic treatment alone may be considered depending on patient preference after discussing adverse events and outcomes. Primarily non-antibiotic options are recommended for prophylaxis of recurrent urinary tract infection. Conclusion: In accordance with the global antibiotic stewardship initiative and considering new insights in scientific research, we updated our German clinical UTI guideline to promote a responsible antibiotic use and to give clear hands-on recommendations for the diagnosis and management of UTIs in adults in Germany for healthcare providers and patients. (c) 2018 S. Karger AG, Basel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据